Effect of allergen immunotherapy with standardized vaccine in patients with allergic asthma and rhinitis

Objective We sought to assess the effect of allergen immunotherapy (AIT) with Alutard? SQ in patients with allergic asthma and rhinitis. Methods Designed the questionnaire and surveyed 39 patients with allergic asthma and rhinitis accepting AIT with Alutard? SQ allergen extract so that we can know their situation before and after accepting AIT. We used levels of asthma control and Asthma Control Test(ACT)to evaluate their levels of asthma control, and used Rhinitis condition score (RCT) to evaluated their rhinitis control. Results 39 subjects completed the survey, and the results showed: AIT resulted in a significant improvement in levels of asthma control( Z = - 7. 235, P <0. 05), ACT (t =16.533, P <0. 05), RCT (t =16.650, P <0. 05) and mood(x2= 34. 873, P <0. 05). Conclusions AIT with Alutard? SQ significantly improved symptoms of the patients with allergic asthma and rhinitis. Key words: Allergen immunotherapy;  Bronchial asthma;  Allergic rhinitis;  Alutard? SQ;  Questionnaire